The estimated Net Worth of Capital Fund, Lp Acuta is at least $7.07 millió dollars as of 4 January 2018. Capital Acuta owns over 54,463 units of IRIDEX stock worth over $7,070,786 and over the last 7 years Capital sold IRIX stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Capital Acuta IRIX stock SEC Form 4 insiders trading
Capital has made over 6 trades of the IRIDEX stock since 2017, according to the Form 4 filled with the SEC. Most recently Capital bought 54,463 units of IRIX stock worth $55,008 on 4 January 2018.
The largest trade Capital's ever made was buying 336,681 units of IRIDEX stock on 4 January 2018 worth over $390,550. On average, Capital trades about 153,384 units every 31 days since 2017. As of 4 January 2018 Capital still owns at least 3,483,146 units of IRIDEX stock.
You can see the complete history of Capital Acuta stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Capital Acuta's mailing address?
Capital's mailing address filed with the SEC is 1301 Shoreway Rd #350, Belmont, CA 94002, USA.
Insiders trading at IRIDEX
Over the last 21 years, insiders at IRIDEX have traded over $1,952,092 worth of IRIDEX stock and bought 1,330,571 units worth $7,196,100 . The most active insiders traders include Joshua Makower, James B Hawkins és Capital Fund, Lp Acuta. On average, IRIDEX executives and independent directors trade stock every 32 days with the average trade being worth of $18,723. The most recent stock trade was executed by Nandini Devi on 20 May 2022, trading 2,000 units of IRIX stock currently worth $6,200.
What does IRIDEX do?
iridex corporation, founded in 1989, is a worldwide leader in developing, manufacturing, and marketing innovative and versatile light-based medical systems and delivery devices. we offer laser based solutions for multiple specialties including aesthetic medicine, ophthalmology, and otolaryngology. we also maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. with superior technology for superior results, iridex is dedicated to standards of excellence that meet your own.
What does IRIDEX's logo look like?
Complete history of Capital Acuta stock trades at IRIDEX
IRIDEX executives and stock owners
IRIDEX executives and other stock owners filed with the SEC include:
-
David Bruce,
President, Chief Executive Officer, Director -
Fuad Ahmad,
Interim Chief Financial Officer -
Patrick Mercer,
Chief Operating Officer -
David I. Bruce,
Pres, CEO & Director -
Patrick Mercer,
Chief Operating Officer -
Fuad Ahmad,
Interim Chief Financial Officer -
Doris Engibous,
Independent Director -
Lynn Lewis,
IR Contact Officer -
Robert Gunst,
Independent Chairman of the Board -
Scott Shuda,
Independent Director -
Kenneth Ludlum,
Independent Director -
Robert Grove,
Independent Director -
Leigh Salvo,
Head of Investor Relations -
George R Marcellino,
Director -
Capital Partners, L.P.Blue ...,
-
Ruediger Naumann Etienne,
Director -
Romeo R Dizon,
-
Sanford Fitch,
Director -
Atabak Mokari,
CFO and VP Corp Development -
Ronald Steckel,
VP, Operations -
Capital Partners, L.P.Blue ...,
-
Associates & Paragon Associ...,
-
William M Moore,
Director -
James H Mackaness,
Chief Financial Officer -
Barry G Caldwell,
President and CEO -
Larry Tannenbaum,
Chief Financial Officer -
James L Donovan,
VP, Corporate Business Develp. -
Beverly A Huss,
Director -
Ann D Rhoads,
Director -
Maria Sainz,
Director -
Ken Ludlum,
Director -
Capital Fund, Lp Acuta,
10% owner -
John M Nehra,
Director -
Joshua Makower,
Director -
Nandini Devi,
Director -
Capital Partners, L.P.Blue ...,
-
Catalyst Fund Ix, L.P.Blue ...,
-
Catalyst Fund Ix, L.P.Blue ...,
-
James B Hawkins,
Director -
Garrett A Garrettson,
Director -
Catalyst Fund Ix, L.P.Blue ...,
-
Eduardo Arias,
Sr. VP, Int'l Sales & Bus... -
Robert K Anderson,
Director -
Partners, L.L.C.Blue Line P...,
-
Dominik Beck,
President and CEO -
Partners, L.L.C.Blue Line C...,
-
Donald J Todd,
VP Marketing -
Capital Partners Ii, L.P.Bl...,
-
Partners, L.L.C.Blue Line C...,
-
Theodore A Boutacoff,
President and CEO -
Timothy S Powers,
Vice President, Operations -
Partners, L.L.C.Blue Line C...,
-
Partners, L.L.C.Blue Line P...,
-
Donald L Hammond,
Director -
Partners, L.L.C.Blue Line C...,
-
Partners, L.L.C.Blue Line C...,